Movatterモバイル変換


[0]ホーム

URL:


SG11201805493YA - Binding members with altered diversity scaffold domains - Google Patents

Binding members with altered diversity scaffold domains

Info

Publication number
SG11201805493YA
SG11201805493YASG11201805493YASG11201805493YASG11201805493YASG 11201805493Y ASG11201805493Y ASG 11201805493YASG 11201805493Y ASG11201805493Y ASG 11201805493YASG 11201805493Y ASG11201805493Y ASG 11201805493YASG 11201805493Y ASG11201805493Y ASG 11201805493YA
Authority
SG
Singapore
Prior art keywords
sawston
iontas
international
high street
binding members
Prior art date
Application number
SG11201805493YA
Inventor
Vellatt Aneesh Karatt
John Mccafferty
Sachin Surade
Tim Luetkens
Edward Masters
Michael Dyson
Original Assignee
Iontas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1600341.0Aexternal-prioritypatent/GB201600341D0/en
Priority claimed from GBGB1621070.0Aexternal-prioritypatent/GB201621070D0/en
Application filed by Iontas LtdfiledCriticalIontas Ltd
Publication of SG11201805493YApublicationCriticalpatent/SG11201805493YA/en

Links

Classifications

Landscapes

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 13 July 2017 (13.07.2017) WIPO I PCT (10) International Publication Number WO 2017/118761 Al 1111111111111101110111111111110101111101110111011111101111111111011111111111110111111 (51) International Patent Classification: C12N 15/10 (2006.01) (21) International Application Number: PCT/EP2017/050337 (22) International Filing Date: 9 January 2017 (09.01.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 1600341.0 8 January 2016 (08.01.2016) GB 1621070.0 12 December 2016 (12.12.2016) GB (71) Applicant: IONTAS LTD [GB/GB]; 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). (72) Inventors: KARATT VELLATT, Aneesh; Iontas Ltd, 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). MCCAFFERTY, John; Iontas Ltd, 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). SURADE, Sachin; Iontas Ltd, 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). LUETKENS, Tim; 1163 E 200 S., Salt Lake City, UT 84102 (US). MASTERS, Edward,; Iontas Ltd, 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). DYSON, Michael; Iontas Ltd, 82B High Street, Sawston, Cambridge Cambridgeshire CB22 3HJ (GB). (74) Agents: SUTCLIFFE, Nicholas et al.; Mewburn Ellis LLP, City Tower, 40 Basinghall Street, London Greater London EC2V 5DE (GB). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) W O 20 171187 / 6 1 Al (54) Title: BINDING MEMBERS WITH ALTERED DIVERSITY SCAFFOLD DOMAINS (57) : This invention relates to libraries of binding members that each comprise a fusion protein which contains a donor di - versity scaffold domain, such as a cysteine rich protein,inserted within a recipient diversity scaffold domain,such as an antibody con- stant or variable domain. Libraries and methods of generating libraries are provided, along with screening methods, binding mem- bers and methods of using the binding members.
SG11201805493YA2016-01-082017-01-09Binding members with altered diversity scaffold domainsSG11201805493YA (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
GBGB1600341.0AGB201600341D0 (en)2016-01-082016-01-08Diversity scaffolds
GBGB1621070.0AGB201621070D0 (en)2016-12-122016-12-12Diversity scaffolds
PCT/EP2017/050337WO2017118761A1 (en)2016-01-082017-01-09Binding members with altered diversity scaffold domains

Publications (1)

Publication NumberPublication Date
SG11201805493YAtrue SG11201805493YA (en)2018-07-30

Family

ID=57868216

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11201805493YASG11201805493YA (en)2016-01-082017-01-09Binding members with altered diversity scaffold domains

Country Status (11)

CountryLink
US (1)US20190256840A1 (en)
EP (2)EP3277810B8 (en)
JP (2)JP7308505B2 (en)
KR (1)KR20180100132A (en)
CN (1)CN108473987B (en)
AU (1)AU2017205706B2 (en)
BR (1)BR112018013883A2 (en)
CA (1)CA3010231A1 (en)
GB (1)GB2562933B (en)
SG (1)SG11201805493YA (en)
WO (1)WO2017118761A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
KR102423377B1 (en)2013-08-052022-07-25트위스트 바이오사이언스 코포레이션De novo synthesized gene libraries
US10669304B2 (en)2015-02-042020-06-02Twist Bioscience CorporationMethods and devices for de novo oligonucleic acid assembly
US9981239B2 (en)2015-04-212018-05-29Twist Bioscience CorporationDevices and methods for oligonucleic acid library synthesis
CA2998169A1 (en)2015-09-182017-03-23Twist Bioscience CorporationOligonucleic acid variant libraries and synthesis thereof
KR102794025B1 (en)2015-09-222025-04-09트위스트 바이오사이언스 코포레이션 Flexible substrates for nucleic acid synthesis
EP3384077A4 (en)2015-12-012019-05-08Twist Bioscience Corporation FUNCTIONALIZED SURFACES AND THEIR PREPARATION
SG11201901563UA (en)2016-08-222019-03-28Twist Bioscience CorpDe novo synthesized nucleic acid libraries
US10417457B2 (en)2016-09-212019-09-17Twist Bioscience CorporationNucleic acid based data storage
EA201991262A1 (en)2016-12-162020-04-07Твист Байосайенс Корпорейшн LIBRARIES OF OPTIONS OF IMMUNOLOGICAL SYNAPSIS AND THEIR SYNTHESIS
CN110892485B (en)2017-02-222024-03-22特韦斯特生物科学公司Nucleic acid-based data storage
CA3056388A1 (en)2017-03-152018-09-20Twist Bioscience CorporationVariant libraries of the immunological synapse and synthesis thereof
MY206158A (en)2017-05-242024-12-02Novartis AgAntibody-cytokine engrafted proteins and methods of use in the treatment of cancer
WO2018231864A1 (en)2017-06-122018-12-20Twist Bioscience CorporationMethods for seamless nucleic acid assembly
IL271205B2 (en)2017-06-122025-02-01Twist Bioscience CorpMethods for seamless nucleic acid assembly
US11407837B2 (en)2017-09-112022-08-09Twist Bioscience CorporationGPCR binding proteins and synthesis thereof
KR102637566B1 (en)2017-10-202024-02-16트위스트 바이오사이언스 코포레이션 Heated nanowells for polynucleotide synthesis
SG11202006460SA (en)2018-01-042020-08-28Twist Bioscience CorpDna-based digital information storage
EP3814497A4 (en)2018-05-182022-03-02Twist Bioscience Corporation POLYNUCLEOTIDES, REAGENTS, AND METHODS FOR NUCLEIC ACID HYBRIDIZATION
CN109106942B (en)*2018-09-182019-11-22深圳瑞健生物科技有限公司 Application of a polypeptide capable of passing through the blood-brain barrier in the preparation of medicines
CN119708086A (en)2018-12-262025-03-28特韦斯特生物科学公司Highly accurate de novo polynucleotide synthesis
US11492727B2 (en)2019-02-262022-11-08Twist Bioscience CorporationVariant nucleic acid libraries for GLP1 receptor
CN113785057A (en)2019-02-262021-12-10特韦斯特生物科学公司 Variant nucleic acid libraries for antibody optimization
WO2020257612A1 (en)2019-06-212020-12-24Twist Bioscience CorporationBarcode-based nucleic acid sequence assembly
WO2021061829A1 (en)2019-09-232021-04-01Twist Bioscience CorporationVariant nucleic acid libraries for crth2
WO2021061842A1 (en)2019-09-232021-04-01Twist Bioscience CorporationVariant nucleic acid libraries for single domain antibodies
EP4384614A4 (en)*2021-08-122025-07-02Univ Hong Kong MATERIALS AND METHODS FOR THE COMPLETE DEFINITION OF ADAPTIVE IMMUNE RESPONSES
CN115035947B (en)*2022-06-102023-03-10水木未来(北京)科技有限公司Protein structure modeling method and device, electronic device and storage medium

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4275149A (en)1978-11-241981-06-23Syva CompanyMacromolecular environment control in specific receptor assays
US4318980A (en)1978-04-101982-03-09Miles Laboratories, Inc.Heterogenous specific binding assay employing a cycling reactant as label
GB9206318D0 (en)1992-03-241992-05-06Cambridge Antibody TechBinding substances
GB9015198D0 (en)1990-07-101990-08-29Brien Caroline J OBinding substance
US6172197B1 (en)1991-07-102001-01-09Medical Research CouncilMethods for producing members of specific binding pairs
US6492160B1 (en)1991-05-152002-12-10Cambridge Antibody Technology LimitedMethods for producing members of specific binding pairs
US5858657A (en)1992-05-151999-01-12Medical Research CouncilMethods for producing members of specific binding pairs
US5962255A (en)1992-03-241999-10-05Cambridge Antibody Technology LimitedMethods for producing recombinant vectors
DE69230142T2 (en)1991-05-152000-03-09Cambridge Antibody Technology Ltd. METHOD FOR PRODUCING SPECIFIC BINDING PAIRS
US6225447B1 (en)1991-05-152001-05-01Cambridge Antibody Technology Ltd.Methods for producing members of specific binding pairs
ES2136092T3 (en)1991-09-231999-11-16Medical Res Council PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES.
ES2227512T3 (en)1991-12-022005-04-01Medical Research Council PRODUCTION OF ANTIBODIES AGAINST SELF-ANTIGENS FROM REPERTORIES OF ANTIBODY SEGMENTS FIXED IN A PHOTO.
US5872215A (en)1991-12-021999-02-16Medical Research CouncilSpecific binding members, materials and methods
US5733743A (en)1992-03-241998-03-31Cambridge Antibody Technology LimitedMethods for producing members of specific binding pairs
US7396917B2 (en)*2000-12-052008-07-08Alexion Pharmaceuticals, Inc.Rationally designed antibodies
ATE544785T1 (en)2000-12-052012-02-15Alexion Pharma Inc RATIONALLY DESIGNED ANTIBODIES
EP1660534A2 (en)*2003-08-222006-05-31MedImmune, Inc.Humanization of antibodies
TWI333977B (en)*2003-09-182010-12-01Symphogen AsMethod for linking sequences of interest
EP1709972B1 (en)*2005-04-052011-06-15Affimed Therapeutics AGUse of an antibody against the laminin receptor or laminin receptor precursor for the diagnosis of cancer
EP2271758B1 (en)2008-04-142018-09-12Innovative Targeting Solutions Inc.Sequence diversity generation in immunoglobulins
WO2010017103A2 (en)*2008-08-042010-02-11The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicFully human anti-human nkg2d monoclonal antibodies
US8921281B2 (en)*2009-05-202014-12-30Novimmune S.A.Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
AU2011326164B2 (en)*2010-11-082016-05-05The Board Of Trustees Of The Leland Stanford Junior UniversityFusion proteins comprising an engineered knottin peptide and uses thereof
JP6684490B2 (en)*2012-01-092020-04-22ザ・スクリップス・リサーチ・インスティテュート Ultralong complementarity determining regions and uses thereof
EP2825653A4 (en)2012-03-142016-01-20Innovative Targeting Solutions IncGenerating targeted sequence diversity in fusion proteins
WO2014063012A1 (en)*2012-10-192014-04-24The Board Of Trustees Of The Leland Stanford Junior UniversityConjugated knottin mini-proteins containing non-natural amino acids
GB201302597D0 (en)2013-02-142013-04-03Univ LeedsNovel Synthetic Proteins
JP2016506974A (en)*2013-02-152016-03-07エスバテック − ア ノバルティスカンパニー エルエルシー Acceptor framework for CDR grafting
CN105814074B (en)*2013-07-182020-04-21图鲁斯生物科学有限责任公司 Humanized antibodies with ultralong complementarity determining regions
WO2015017146A2 (en)*2013-07-182015-02-05Fabrus, Inc.Antibodies with ultralong complementarity determining regions
GB201407852D0 (en)*2014-05-022014-06-18Iontas LtdPreparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
GB201720351D0 (en)*2017-12-062018-01-17Iontas LtdSelecting for developability in drug discovery

Also Published As

Publication numberPublication date
JP7308505B2 (en)2023-07-14
RU2018123301A (en)2020-02-10
GB2562933A (en)2018-11-28
BR112018013883A2 (en)2018-12-18
GB201812040D0 (en)2018-09-05
KR20180100132A (en)2018-09-07
CN108473987B (en)2024-01-02
CN108473987A (en)2018-08-31
RU2018123301A3 (en)2020-06-30
WO2017118761A1 (en)2017-07-13
EP3277810A1 (en)2018-02-07
CA3010231A1 (en)2017-07-13
JP2022084834A (en)2022-06-07
JP2019505206A (en)2019-02-28
US20190256840A1 (en)2019-08-22
EP3277810B8 (en)2020-07-15
AU2017205706B2 (en)2022-10-20
EP3277810B1 (en)2020-05-27
GB2562933B (en)2022-06-29
AU2017205706A1 (en)2018-08-16
GB2562933A8 (en)2018-12-19
EP3786292A1 (en)2021-03-03
JP7539018B2 (en)2024-08-23

Similar Documents

PublicationPublication DateTitle
SG11201805493YA (en)Binding members with altered diversity scaffold domains
SG11201807252QA (en)Anti-lag-3 antibodies
SG11201809857TA (en)Anti-CTLA-4 Antibodies
SG11201910019PA (en)Microorganisms and methods for producing cannabinoids and cannabinoid derivatives
SG11201908820VA (en)Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201811184UA (en)Lag -3 binding members
SG11201909949XA (en)Targeted immunotolerance
SG11201805449PA (en)Methods of making chimeric antigen receptor -expressing cells
SG11201907857RA (en)Edible and biodegradable utensils
SG11201805532XA (en)Multivalent and multispecific 41bb-binding fusion proteins
SG11201907210YA (en)Policy communication via control plane signaling
SG11201811431VA (en)Multispecific antibodies against cd40 and cd137
SG11201805422WA (en)Multivalent and multispecific ox40-binding fusion proteins
SG11201900634VA (en)Chimeric antigen receptor
SG11201903857UA (en)Antibodies to pd-1 and uses thereof
SG11201908280SA (en)"chimeric molecules and uses thereof"
SG11201808724SA (en)Anti-tim-3 antibodies and compositions
SG11201903012RA (en)Anti-c1s antibodies and methods of use thereof
SG11201808797XA (en)T cell receptors
SG11201908675PA (en)Computer-implemented system and method for performing transaction mixing on a blockchain
SG11201810983PA (en)Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201809374VA (en)Cd40l-fc fusion polypeptides and methods of use thereof
SG11201810887UA (en)Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof
SG11201807474SA (en)Compositions comprising coformulation of anti-pd-l1 and anti-ctla-4 antibodies
SG11201805204WA (en)Nicotine particle capsule

[8]ページ先頭

©2009-2025 Movatter.jp